â– LECTURE OVERVIEW: Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer, HNPCC) is an autosomal dominant cancer predisposition syndrome characterized by defective DNA mismatch repair.
â– GENETIC AND BIOCHEMICAL BIOCHEMISTRY:
1. Mismatch Repair (MMR) Defect: Caused by germline mutations in DNA Mismatch Repair genes, primarily MSH2, MLH1, MSH6, and PMS2.
2. Single-Base Mispairings: During S-phase replication, DNA polymerases can accidentally introduce single-base mispairs or small insertion-deletion loops.
3. Splicing Corrections: The MMR system scans newly synthesized strands, excises mispaired bases, and resynthesizes correct sequences.
4. Microsatellite Instability (MSI): Microsatellites are short, repetitive, non-coding DNA sequences prone to polymerase slippage. When MMR is defective, these repeat lengths mutate rapidly, creating a hypermutable state termed Microsatellite Instability (MSI).
5. Two-Hit Hypothesis: Tumorigenesis occurs when the somatic wild-type allele is mutated (second-hit), driving rapid progression of colon adenomas into invasive carcinomas.
â– SPECIAL CLINICAL POPULATIONS & METABOLIC DEVIATIONS:
Infants display higher body water ratios and immature renal filtration capacity, whereas geriatric cohorts exhibit reduced physiologic reserves, progressive heart/renal decline, and polypharmacy interactions.
â– SURGICAL COMPASS & ANATOMICAL CORRELATION:
Dissection lines must respect established fascial boundaries to prevent neurovascular traction injuries and secure excellent diagnostic margins.
[HY-BOARD-1194]
🌟 Dynamic Clinical Key:
Lynch syndrome predisposes patients to proximal (right-sided) colon cancers with a notable lack of heavy pre-existing polyposis. It is also associated with a massive lifetime risk of endometrial cancer in women, as well as ovarian, gastric, small bowel, and transitional cell urothelial tract carcinomas. Adjust weight-based dosing for pediatric cohorts and use the 'start low and go slow' approach for seniors. Verify landmarks dynamically with gentle palpation and specialized intraoperative markers.